Albert Sabin and prove its extraordinary effectiveness and safety. The Sabin vaccine worked in the intestines to block the poliovirus from entering the bloodstream. In the intestines, Sabin had discovered, the poliovirus multiplied and attacked. Thus, the oral vaccine broke the chain of transmission of the virus and allowed for the possibility that polio might one day be eradicated. Between 1955 and 1961, the oral vaccine was tested on at least 100 million people in the USSR, parts of Eastern Europe, Singapore, Mexico, and the Netherlands. The first industrial production and mass use of oral poliovirus vaccine (OPV) from Sabin strains was
Albert Kapikian Albert Kapikian Albert Zaven Kapikian (1930 – 2014) was an Armenian-American virologist who developed the first licensed vaccine against rotavirus, the most common cause of severe diarrhea in infants. He was awarded the Sabin Gold Medal for his pioneering work on the vaccine. He is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute. Called the father of human gastroenteritis virus research, Kapikian identified the first norovirus, initially called Norwalk virus, in 1972; and he and his colleagues at the National Institutes of Health identified the hepatitis A virus in 1973. Kapikian graduated from Cornell Medical